Osteonecrosis of the jaw and oral health-related quality of life after adjuvant zoledronic acid: an adjuvant zoledronic acid to reduce recurrence trial subprotocol (BIG01/04)

Rathbone, EJ, Brown, JE, Marshall, HC et al. (11 more authors) (2013) Osteonecrosis of the jaw and oral health-related quality of life after adjuvant zoledronic acid: an adjuvant zoledronic acid to reduce recurrence trial subprotocol (BIG01/04). Journal of Clinical Oncology, 31 (21). 2685 - 2691. ISSN 1527-7755

Abstract

Metadata

Authors/Creators:
  • Rathbone, EJ
  • Brown, JE
  • Marshall, HC
  • Collinson, M
  • Liversedge, V
  • Murden, GA
  • Cameron, D
  • Bell, R
  • Spensley, S
  • Agrawal, R
  • Jyothirmayi, R
  • Chakraborti, P
  • Yuille, F
  • Coleman, RE
Keywords: Adult; aged; antineoplastic combined chemotherapy protocols; bone density conservation agents; breast neoplasms; chemotherapy, adjuvant; diphosphonates; female; humans; imidazoles; jaw diseases; middle aged; oral health; osteonecrosis; quality of life
Dates:
  • Published: 20 July 2013
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 01 Apr 2015 11:33
Last Modified: 27 Apr 2015 10:08
Published Version: http://dx.doi.org/10.1200/JCO.2012.46.4792
Status: Published
Publisher: American Society of Clinical Oncology
Identification Number: https://doi.org/10.1200/JCO.2012.46.4792

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Share / Export

Statistics